Cargando…
Variable CD34(+) recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic
Donor registries and transplantation societies recommend cryopreservation of unrelated donor hemopoietic progenitor cell (HPC) products before the recipient commences conditioning therapy to mitigate the donor and travel risks associated with the COVID-19 pandemic. However, little is known regarding...
Autores principales: | Purtill, Duncan, Antonenas, Vicki, Chiappini, Paul, Tong, Daochen, O’Flaherty, Elizabeth, Bajel, Ashish, Kabani, Karieshma, Larsen, Stephen, Tan, Suikeat, Hutchins, Cheryl, Curtis, David J., Kennedy, Glen A., Watson, Anne-Marie, Bai, LiJun, Greenwood, Matthew, Gottlieb, David J., Hamad, Nada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479963/ https://www.ncbi.nlm.nih.gov/pubmed/32886750 http://dx.doi.org/10.1182/bloodadvances.2020002431 |
Ejemplares similares
-
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic
por: Purtill, Duncan, et al.
Publicado: (2021) -
Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021) -
Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023) -
Cryopreservation: A Review Article
por: Jaiswal, Anurag N, et al.
Publicado: (2022) -
Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry
por: Fernandez-Sojo, Jesus, et al.
Publicado: (2022)